SCHEMBL29348783

SCHEMBL29348783

O=C1CCC(c2cccc(-c3ccc(C(=O)N4CCCCC4)cc3)c2Cl)C(=O)N1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 2/20 0.47
BRD4 O60885 1/20 0.47
CRBN Q96SW2 6/20 0.42
DDB1 Q16531 5/20 0.42
HPGD P15428 3/20 0.41
MAPK1 P28482 1/20 0.41
ALDH1A1 P00352 2/20 0.40
L3MBTL3 Q96JM7 6/20 0.39
L3MBTL1 Q9Y468 5/20 0.39
MBTD1 Q05BQ5 4/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
IKZF3 Q9UKT9 1/20 0.39
NPC1 O15118 1/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 1/20 0.38
CYP2D6 P10635 1/20 0.38
OPRD1 P41143 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31068121 1.00 CREBBP (0.47) CREBBPBRD4CRBNDDB1HPGD
SCHEMBL29348412 0.99 CREBBP (0.48) CREBBPBRD4CRBNDDB1HPGD
SCHEMBL29348447 0.86 HSP90AA1 (0.40) CREBBPBRD4CRBNDDB1HPGD
SCHEMBL31068305 0.86 HSP90AA1 (0.40) CREBBPBRD4CRBNDDB1HPGD
SCHEMBL31068259 0.86 CRBN (0.44) CREBBPBRD4CRBNDDB1ALDH1A1
SCHEMBL31637574 0.86 CRBN (0.44) CREBBPBRD4CRBNDDB1ALDH1A1
SCHEMBL31068201 0.84 KMT2A (0.41) CRBNDDB1ALDH1A1L3MBTL1MEN1
SCHEMBL31068101 0.84 PRKAB2 (0.39) CRBNDDB1HPGDALDH1A1SMN1; SMN2
SCHEMBL29348473 0.84 KMT2A (0.41) CRBNDDB1ALDH1A1L3MBTL1MEN1
SCHEMBL29348461 0.84 PRKAB2 (0.39) CRBNDDB1HPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed